Healthcare regulator MHRA is racing to develop new AI tools that promise to dramatically improve patient care.
It can take days, weeks, or even months for the results of a medical exam to be available. That wait is often filled with anxiety and always feels like an eternity. But what if that wait time could be reduced from weeks to just minutes?
In the next phase of its ‘AI Airlock’ programme, the Medicines and Healthcare products Regulatory Agency (MHRA) is evaluating seven new technologies designed to tackle some of healthcare’s most pressing challenges.
An innovation being tested could reduce the time it takes to get results for a colon cancer test to just a few minutes, allowing for earlier detection of skin cancer and inherited eye diseases. The AI Airlock initiative provides a safe and controlled environment for manufacturers to test these advanced systems. This “regulatory sandbox” will enable the effectiveness and limitations of AI to be assessed, helping to forge a clear path towards final regulatory approval and introduction into healthcare services.
Insights gained from this real-world testing will feed directly into the MHRA’s future regulation of AI as a medical device and into the National Commission on the Regulation of AI in Healthcare. The committee brings together a diverse group of patient advocates, clinicians, regulators, and technology companies to advise the agency.
The seven selected technologies include AI-powered clinical note-taking to reduce the administrative burden on physicians, advanced cancer diagnostics, advanced eye disease detection, and tools that can summarize a patient’s entire hospital stay or interpret complex blood tests. The ultimate goal is to use AI to support clinicians in making faster, better-informed treatment decisions for their patients.
Minister of Health and Innovation Zubir Ahmed said: “The AI Airlock program is a great example of how we can keep pace and thoroughly test new innovations as we seek to deliver on the promise of moving healthcare from analog to digital.”
“Through our 10-year health plan, we will drive the NHS to become the most AI-enabled health system in the world.”
Pioneering the path to secure AI healthcare innovation
Advances in AI pose unique challenges for regulators tasked with ensuring the safety of patient care.
Lawrence Tallon, Chief Executive Officer of the MHRA, commented: “As the first country to create a dedicated regulatory environment, or “sandbox,” specifically for AI medical devices, we are pioneering solutions to the unique challenges of regulating these emerging medical technologies.
“The first phase of AI Airlock demonstrated the value of close collaboration between innovators and regulators, and we look forward to the results of this new cohort and how its technology will shape the next generation of safe and effective AI tools in healthcare.”
This second phase builds on the success of the first pilot. The MHRA has published four reports detailing key findings from the initial group of participants, which included innovative companies such as Philips and OncoFlow.
The AI Airlock program worked with the first cohort to identify several areas for regulatory improvement. These include better ways to validate synthetic data used to train AI models, ensuring that decisions made by AI are “explainable” to clinicians, and developing new approaches to address emerging risks such as AI “hallucinations,” where models produce inaccurate or meaningless information.
“Participating in the AI Airlock sandbox has been a very positive experience. The opportunity for R&D personnel to influence regulatory strategy with regulators is almost unprecedented,” said Ynon Dolev, Gen AI Product Owner at Philips Medical Systems.
“Our interactions with the team and experts were exceptional. They provided valuable insight and support, which made the entire process smooth and productive. Weekly meetings with the MHRA during the pilot also catalyzed meaningful progress that accelerated development activities.”
A clinician’s perspective on using AI tools for patient care
For frontline medical staff, the promise of AI requires caution. Sir Andrew Goddard, Chair of the AI Airlock Governance Committee and Consultant Gastroenterologist at Royal Derby Hospital, highlighted the program’s role in building trust.
“Many clinicians, like me, want AI to take hold in the NHS, but are concerned about over-promising outcomes and a lack of reassurance about patient safety,” Lord Goddard explained. “This program will go a long way in embedding safety and rapid development of these new technologies into our health services.”
By connecting innovators and regulators at an early stage, AI Airlock will help deliver the next wave of medical technology to improve patient care, but in a way that is safe, reliable, and worthy of the trust of both patients and physicians.
See also: NVIDIA GPUs power Oracle’s next-generation enterprise AI services
Want to learn more about AI and big data from industry leaders? Check out the AI & Big Data Expo in Amsterdam, California, and London. This comprehensive event is part of TechEx and co-located with other major technology events such as Cyber Security Expo. Click here for more information.
AI News is brought to you by TechForge Media. Learn about other upcoming enterprise technology events and webinars.
